Conflict of interest: MH has provided consultancy services to AstraZeneca, Novo Nordisk, Merck & Co., and HoffmanLa Roche with respect to incretin-targeted therapeutics and has received investigator-initiated research grants from Novo Nordisk and Merck & Co
This medication can also be appealing to patients looking for the convenience of a once weekly injection
Patients need guidance on food choices, maintenance habits, portion control, and avoiding relapse into the behaviors that led to weight gain
Vniant MM, Lu SC, Atangan L, Komorowski R, Stanislaus S, Cheng Y, et al
SGLT2is provide cardio-renal benefits, despite an increase in the risk of DKA and urinary tract infection compared with GLP-1 RA therapy
Both sides agreed the shortage is factually over today